4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
HBL - Hadasit Bio-Holdings Ltd (HDST-M) operates in the Biotechnology industry and is headquartered in Jerusalem, Israel with about 1 employees. Its market capitalization is roughly ₪7 million. In the fiscal year ended 2025-12-31, HDST-M reported ₪0M in revenue and (₪2M) in net income.
HBL - Hadasit Bio-Holdings Ltd engages in the medical and biotechnology research and development activities in Israel. The company's portfolios are developing novel protein drugs for cancer immunotherapy and stem cell-based therapies for the treatment of eye diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | ₪0M | ₪0M | ₪0M | ₪0M | — |
| Operating Income (EBIT) | (₪2M) | (₪2M) | (₪2M) | (₪3M) | — |
| Net Income | (₪2M) | (₪4M) | (₪29M) | (₪31M) | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | ₪2M | ₪3M | ₪8M | ₪39M | — |
| Total Liabilities | ₪2M | ₪1M | ₪3M | ₪4M | — |
ILS; ₪M / ₪B as marked. Newest period first. Source: company filings via the Israel Securities Authority’s Magna disclosure system.
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HDST-M viewer.
This page in other languages: עברית
About TickerBase · Data methodology & sources · Privacy · Terms